Skip to main content

Navigation group

Type at least 3 characters
893 articles

Articles

Original Research

Published on 08 May 2024

Single-cell transcriptomic analysis of hematopoietic progenitor cells from patients with systemic lupus erythematosus reveals interferon-inducible reprogramming in early progenitors

in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

  • Anastasia Filia
  • Ioannis Mitroulis
  • Catherine Loukogiannaki
  • Maria Grigoriou
  • Aggelos Banos
  • George Sentis
  • Stavroula Giannouli
  • Vassiliki Karali
  • Emmanouil Athanasiadis
  • Ioannis Kokkinopoulos
Single-cell transcriptomic analysis of hematopoietic progenitor cells from patients with systemic lupus erythematosus reveals interferon-inducible reprogramming in early progenitors
Frontiers in Immunology
doi 10.3389/fimmu.2024.1383358

Original Research

Accepted on 06 May 2024

Drug survival superiority of tumor necrosis factor inhibitors and interleukin-17 inhibitors over Janus kinase inhibitors and interleukin-12/23 inhibitors in German psoriatic arthritis outpatients: Retrospective analysis of the RHADAR database.

in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

  • Patrick-Pascal Strunz
  • Matthias Englbrecht
  • Linus Maximilian Risser
  • Torsten Witte
  • Matthias Fröhlich
  • Marc Schmalzing
  • Michael Gernert
  • Astrid Schmieder
  • Peter Bartz-Bazzanella
  • Cay von der Decken
Frontiers in Immunology
doi 10.3389/fimmu.2024.1395968

Original Research

Accepted on 06 May 2024

Disease severity, treatment patterns and quality of life in patients with moderate-to-severe psoriasis routinely managed with systemic treatment: Results of the CRYSTAL observational study in Central and Eastern European countries

in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

  • Liisi Raam
  • Ilona Hartmane
  • Skaidra Valiukeviciene
  • Arfenia Karamova
  • Eniko Telegdy
  • Ivan Botev
  • Diana Marina
  • Simone Rubant
  • Teotonio Albuquerque
  • Maria Magdalena Constantin
Frontiers in Immunology
doi 10.3389/fimmu.2024.1410540